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Paravertebral blocks and enhanced recovery
after surgery protocols in breast reconstructive
surgery: patient selection and perspectives

Rajiv P Parikh
Terence M Myckatyn
Department of Surgery, Division of
Plastic and Reconstructive Surgery,
Washington University School of
Medicine, St Louis, MO, USA

Abstract: The management of postoperative pain is of critical importance for women undergoing breast reconstruction after surgical treatment for breast cancer. Mitigating postoperative
pain can improve health-related quality of life, reduce health care resource utilization and costs,
and minimize perioperative opiate use. Multimodal analgesia pain management strategies with
nonopioid analgesics have improved the value of surgical care in patients undergoing various
operations but have only recently been reported in reconstructive breast surgery. Regional anesthesia techniques, with paravertebral blocks (PVBs) and transversus abdominis plane (TAP)
blocks, and enhanced recovery after surgery (ERAS) pathways have been increasingly utilized
in opioid-sparing multimodal analgesia protocols for women undergoing breast reconstruction.
The objectives of this review are to 1) comprehensively review regional anesthesia techniques
in breast reconstruction, 2) outline important components of ERAS protocols in breast reconstruction, and 3) provide evidence-based recommendations regarding each intervention included
in these protocols. The authors searched across six databases to identify relevant articles. For
each perioperative intervention included in the ERAS protocols, the literature was exhaustively
reviewed and evidence-based recommendations were generated using the Grading of Recommendations, Assessment, Development, and Evaluation system methodology. This study provides
a comprehensive evidence-based review of interventions to optimize perioperative care and
postoperative pain control in breast reconstruction. Incorporating evidence-based interventions into future ERAS protocols is essential to ensure high value care in breast reconstruction.
Keywords: enhanced recovery after surgery, ERAS, postmastectomy breast reconstruction,
autologous flap, breast implant
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Breast reconstruction after surgical treatment for breast cancer has the potential to
significantly improve patients’ health-related quality of life.1–7 Although most women
report greater satisfaction with appearance and improved physical, psychosocial, and
sexual well-being following breast reconstruction, the management of postoperative pain
remains challenging. Inadequate postoperative pain control contributes to unnecessary
health care resource utilization while exacerbating costs and hindering patient recovery.
This is true for both implant-based (prosthetic) and microvascular (autologous) breast
reconstruction techniques. Nearly one-half of patients undergoing breast reconstruction
experience postoperative pain syndromes.8,9 Inadequately controlled acute postoperative
pain is associated with an increased likelihood of developing persistent postsurgical
pain, which reduces the quality of life.8–12 Additionally, poorly controlled pain may result
in a prolonged opioid dependency, contributing to the ongoing opioid epidemic in the
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United States.13,14 Furthermore, postoperative pain negatively
impacts the quality of recovery (QoR) and satisfaction.15–17
There is evidence that a decrease in QoR secondary to pain
can prolong hospital stay, delay return to normal daily living,
and reduce the quality of life.15–19 Thus, opioid-sparing analgesic strategies to improve postoperative pain control, reduce
length of stay (LOS), and minimize resource utilization are
essential to improve the overall quality and value of care for
patients undergoing breast reconstruction.20–22
Recently, there have been a few interventions introduced
that have promise in optimizing pain control and postoperative recovery for women with breast cancer undergoing breast
reconstruction. The most prevalent of these are regional
anesthesia techniques, including paravertebral blocks (PVBs)
and transversus abdominis plane (TAP) blocks, and evidencebased multimodal perioperative management approaches,
referred to as Enhanced Recovery after Surgery (ERAS)
protocols. The purported strengths of these interventions are
that they significantly improve the value of surgical care by
enhancing postoperative recovery.23–27 ERAS protocols utilize
evidence-based recommendations to standardize perioperative
care.28 Although widely adopted in various surgical disciplines, there was minimal literature on opioid-sparing multimodal analgesia strategies in reconstructive breast surgery
until recently.29 As a result, perioperative approaches have
traditionally been based on individual experience and differed
tremendously across institutions, potentially contributing to
variations in system-wide quality and unnecessary resource
utilization. Therefore, the goals of this article are to 1) comprehensively review regional anesthesia techniques in breast
reconstruction, 2) outline important components of ERAS
protocols in breast reconstruction, and 3) provide evidencebased recommendations regarding all perioperative interventions aimed at enhancing recovery in breast reconstruction.

Methods
This study was conducted in the following two stages: 1)
comprehensive review of regional analgesic techniques and
ERAS protocols in breast reconstruction and 2) literature
review and generation of evidence-based recommendations
for all interventions included in ERAS protocols for breast
reconstruction. The authors followed the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines throughout this investigation.30,31

of Science, Cochrane Central Register of Controlled Trials,
and ClinicalTrials.gov databases from January 1990 through
October 2017 using strategies designed by a medical librarian
for the concepts of breast reconstruction, regional analgesia,
perioperative care or fast track or enhanced recovery, and
LOS, postoperative complications, or pain. All results were
exported to EndNote, and duplicate citations were removed.
References were then hand-searched, and relevant articles
were retrieved. All studies reporting patients undergoing
breast reconstruction in an ERAS protocol or with regional
analgesia techniques were eligible for inclusion. Articles in
all languages were considered. A study was excluded if full
text could not be obtained.

Evidence-based recommendations for
ERAS protocol items
In the second stage, we performed a literature review of
each intervention included in the previously identified
ERAS protocols with search parameters for [X] and breast
reconstruction, where X = specific intervention in the ERAS
protocol. For each item, searches were performed to identify
the best available evidence, with priority given to metaanalyses, systematic reviews, and randomized-controlled
trials (RCTs). In the absence of high-quality evidence specific to breast reconstruction, we included nonrandomized
observational studies and/or extrapolated evidence from the
surgical literature. Consistent with other studies, we used the
Grading of Recommendations, Assessment, Development,
and Evaluation (GRADE) system to appraise the overall
quality of evidence for each intervention and to assign a
level of strength to each recommendation.32–36 The GRADE
system is widely adopted, and the preferred methodology of
The Cochrane Collaboration and the Agency for Healthcare
Research and Quality (AHRQ) for grading clinical evidence
and developing recommendations for clinical practice is
used.37 The GRADE approach classifies recommendations
into two levels, such as strong (Grade 1) and weak (Grade 2),
and then subclassifies each grade into three categories based
on the quality of evidence (A = high quality, B = moderate
quality, and C = low quality).38–40 The strength of recommendation is primarily influenced by the tradeoff between
the benefits, risks, and burdens of an intervention and by the
quality of the evidence available.

Review of regional analgesia techniques and
ERAS protocols in breast reconstruction

Regional analgesic techniques in
breast reconstruction

To identify regional analgesia and ERAS protocols, we
searched the Ovid MEDLINE, EMBASE, SCOPUS, Web

Regional anesthesia techniques are utilized across surgical
disciplines and have demonstrated efficacy at reducing both
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acute and chronic postoperative pain, opiate use, and LOS
for various surgical procedures.41 In reconstructive breast
surgery, the two most common techniques for regional
anesthesia are PVBs and TAP blocks. PVBs are utilized in
both prosthetic and autologous breast reconstruction procedures, whereas TAP blocks only have utility in abdominally
based autologous breast reconstruction procedures such as
deep inferior epigastric artery perforator (DIEP) flaps and
transverse rectus abdominis myocutaneous (TRAM) flaps.
Traditionally, regional blocks or infusions were performed
with bupivacaine, which has a duration of action between 8
and 12 hours. However, recently, several groups have shifted
toward using liposomal bupivacaine, which has a duration of
action ranging from 72 to 96 hours.42 Although comparative
studies evaluating cost and outcomes between bupivacaine
and liposomal bupivacaine are still needed, there is preliminary evidence to demonstrate the efficacy and merit the use
of liposomal bupivacaine in reconstructive breast surgery.43

TAP blocks
TAP blocks were initially introduced in the literature in
the early 2000s and have subsequently gained widespread
acceptance as an effective technique for regional anesthesia
in various abdominally based surgical operations.44,45 In
abdominally based autologous breast reconstruction procedures, TAP blocks were first reported as having efficacy for
improving pain control and reducing opiate requirements by
Hivelin et al46 in 2011. To date, there is evidence from one
RCT, two prospective cohort studies, and two retrospective
studies demonstrating that TAP blocks are safe and significantly reduce postoperative opioid use in abdominally based
autologous breast reconstruction.46–50 There are several excellent articles that detail the relevant anatomy and technical
components of performing a TAP block.51,52 Briefly, TAP
blocks involve anesthetizing the sensory innervation to the
anterior abdominal wall, which is traditionally considered
to be derived from the T6-L1 nerves from the anterior rami
of the thoracolumbar spinal nerves.51,52 The lumbar triangle
of Petit is often used as the primary landmark to localize the injection to the plane between the internal oblique
musculature and the transversus abdominis musculature. In
autologous breast reconstruction, this block is performed
under direct visualization following flap harvest and prior
to closure of the abdominal donor site. A blunt tip injection
cannula is inserted into the TAP and local anesthetic in the
form of bupivacaine or liposomal bupivacaine is injected.
Alternatively, a catheter can also be introduced in the plane
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and redosed periodically in the perioperative period.47,48 For
bilateral procedures, bilateral blocks are performed.

PVBs
There is considerable evidence supporting the use of PVBs
in breast surgery. In a meta-analysis of 15 RCTs in breast
cancer surgery, PVBs were determined to be effective at
reducing postoperative pain and hospital LOS.53 In reconstructive breast surgery, there is literature to support the use
of PVBs in both prosthetic breast reconstruction and autologous breast reconstruction procedures. A recent prospective
study by Parikh et al54 demonstrated a significant reduction
in postoperative pain and LOS for women with breast cancer
undergoing postmastectomy abdominally based autologous
breast reconstruction with a PVB compared to women
who did not receive a PVB. In a follow-up study from the
same group, the authors also reported a reduction in opiate
medication requirements for patients undergoing autologous
breast reconstruction with use of a PVB compared to patients
undergoing autologous breast reconstruction without a
PVB.55 Of importance, the use of PVBs did not compromise
intraoperative perfusion or change fluid requirements in this
cohort. The value of PVBs is not confined to abdominally
based breast reconstruction. In 2016, Unkart et al56 reported
their experience with PVBs for patients undergoing breast
reconstruction with latissimus dorsi autologous flaps. In prosthetic breast reconstruction, there are several retrospective
cohort studies and one RCT that similarly confirm the value
of PVBs versus general anesthesia alone. Coopey et al57 and
Fahy et al58 independently demonstrated reductions in LOS,
perioperative opiate use, and postoperative pain for patients
undergoing immediate prosthetic breast reconstruction with
a PVB compared to patients who did not receive a PVB.
This reduction in perioperative opiate use was subsequently
confirmed in a 2015 report by Glissmeyer et al,59 where the
authors reported that morphine equivalents were significantly
lower in the cohort of patients who received a PVB in postmastectomy breast reconstruction compared to the cohort
of patients who did not. In 2016, Wolf et al reported results
from the first prospective RCT of PVBs in prosthetic breast
reconstruction. In a total of 74 patients (35 who received a
PVB and 34 in the control group), the authors demonstrated
that patients who received a PVB, compared to patients who
did not, required significantly less opiates intraoperatively
and postoperatively, had lower pain scores postoperatively,
and required less antiemetic medications perioperatively.60
These procedures can be performed with consistency and
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with minimal risk for complications, as confirmed in a 2016
report of 856 patients undergoing 1427 PVBs for regional
anesthesia in postmastectomy prosthetic reconstructive
breast surgery procedures where the complication rate was
<1.0%.61 Similar to TAP blocks, there are excellent articles
that detail the anatomical and technical considerations for
performing PVBs.61,62 Briefly, our preferred approach is to
inject 15–20 mL of 0.5% bupivacaine (bilateral for bilateral
procedures) at the T2–T4 paravertebral spaces under ultrasound guidance in the immediate preoperative setting.54,55
These procedures are performed by fellowship trained anesthesiologists on a dedicated regional block team.

Recommendation: There is moderate-quality evidence to
support the inclusion of regional analgesic techniques with
TAP blocks and PVBs in ERAS protocols for microvascular
breast reconstruction and PVBs for prosthetic breast reconstruction (Grade 1B).

ERAS protocols in breast
reconstruction
Following review, there were five nonrandomized studies
from four different institutions that evaluated ERAS protocols
in breast reconstruction (Table 1).63–67 In total, studies evaluated 49 patients undergoing prosthetic reconstruction and 661

Table 1 Characteristics of studies comparing breast reconstruction outcomes for patients in an ERAS protocol to conventional care
Authors

Location

Year

Methods

Participants
in ERAS
protocol, n

Participants
in usual care
protocol, n

Perioperative interventions
included in ERAS protocol

Outcomes

Batdorf
et al64

USA

2015

Retrospective
cohort

49

51

Length of stay,
total opiate use,
pain scores, flap
loss, systemic
complications, surgical
complications

Bonde
et al65

Denmark

2015

Case–control

177

277

Bonde
et al66

Denmark

2016

Retrospective
cohort

16

N/A

Afonso
et al63

USA

2017

Retrospective
cohort

42

49

Dumestre
et al67

Canada

2017

Retrospective
cohort

29

29

Preoperative education; fasting only
2 hours for clear liquids prior to
surgery; antimicrobial prophylaxis;
multimodal analgesia with opiates,
NSAIDs, acetaminophen, gabapentin
+ TAP blocks with liposomal
bupivacaine; euvolemia fluid
management; antiemetics; oral feeding
on POD 0; early ambulation; urinary
catheter removal POD 1
Preoperative education; antimicrobial
prophylaxis; multimodal analgesia
with opiates (on request), NSAIDs
and acetaminophen; early ambulation;
urinary catheter removal POD 1
Preoperative education; antimicrobial
prophylaxis; multimodal analgesia
with opiates (on request), NSAIDs,
acetaminophen, and gabapentin;
minimally invasive approach (DIEP
flaps only); oral feeding on POD 1;
early ambulation; urinary catheter
removal POD 1
Preoperative education; fasting only
2 hours for clear liquids prior to
surgery; multimodal analgesia with
opiates, NSAIDs (IV ketorolac), and
acetaminophen + TAP blocks with
liposomal bupivacaine; goal-directed
fluid management; antiemetics; oral
feeding on POD 1; early ambulation;
urinary catheter removal POD 1
Preoperative education; fasting only
3 hours for clear liquids prior to
surgery; multimodal analgesia with
opiates, celecoxib/NSAIDs, and
acetaminophen + local nerve blocks
with bupivacaine

Length of stay,
surgical complications,
flap loss

Length of stay,
surgical complications,
flap loss

Length of stay,
total opiate use,
pain scores, flap
loss, systemic
complications, surgical
complications

Length of stay,
QoR scores, pain
scores, systemic
complications, surgical
complications

Abbreviations: DIEP, deep inferior epigastric artery perforator; ERAS, enhanced recovery after surgery; NSAIDs, nonsteroidal anti-inflammatory drugs; POD, postoperative
day; QoR, quality of recovery; TAP, transversus abdominis plane; N/A, not available.

1570

Powered by TCPDF (www.tcpdf.org)

submit your manuscript | www.dovepress.com

Dovepress

Journal of Pain Research 2018:11

Journal of Pain Research downloaded from https://www.dovepress.com/ by 128.252.174.220 on 20-Oct-2018
For personal use only.

Dovepress

patients undergoing 783 microvascular flaps for autologous
reconstruction. Of them, 29 patients undergoing prosthetic
reconstruction and 284 patients undergoing 345 flaps were
treated in an ERAS protocol, whereas 29 patients undergoing prosthetic reconstruction and 377 patients undergoing
438 flaps were treated with conventional care. There were
two studies from the same group: the first study, published
in 2015, compared an ERAS protocol with conventional
care and the second study, published in 2016, reported on
16 patients in a modified ERAS protocol, which was then
compared with their previously published data on patients
in the first version of the ERAS protocol.65,66 There was
substantial heterogeneity between the treatment protocols,
patient groups, comorbidities reported, and postoperative
outcomes measured; therefore, quantitative analyses across
studies were not feasible. In regard to outcomes reported, all
studies reported LOS, but only three studies reported postoperative pain scores, two studies reported opiate use, and three
studies reported systemic complications. No study reported
cost outcomes. Additionally, data on relevant covariates or
potential confounders were inconsistently reported.

Evidence-based recommendations
for components of ERAS protocols
Preoperative interventions
Patient education/counseling

Preoperative patient education and counseling are essential to
patient-centered care, one of the key domains of high-quality
health care.68 Patient education and counseling should address
patients’ expectations, include a comprehensive discussion
of the risks and benefits of different treatment options, assess
patients’ understanding of their expected perioperative
course, and involve patients in the decision-making process.69,70 In breast reconstruction, several studies, utilizing
the BREAST-Q patient-reported outcome measure, have
shown a positive association between patient’s satisfaction
with preoperative information and postoperative outcome.71,72
Additionally, Sheehan et al73 and Zhong et al74 independently
demonstrated that lower satisfaction with preparatory information is associated with an increased likelihood of regret
following breast reconstruction. When expanded across
surgical specialties, there is also evidence that preoperative
education is an independent predictor of reduced LOS in
ERAS protocols.75–77
Recommendation: Preoperative education is integral
to patient-centered care and has the potential to improve
postoperative patient-reported outcomes while minimizing
decision regret. The impact of patient education on LOS
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has not been examined in breast reconstruction; however,
there are minimal risks associated with this intervention.
Consequently, we strongly recommend ERAS protocols in
breast reconstruction that incorporated preoperative education and counseling, ideally in a shared decision-making
model (Grade 1B).

Fasting, nutrition, and carbohydrate loading
In two of the ERAS protocols for breast reconstruction,
preoperative fasting from the intake of clear liquids for at
least 2 hours prior to surgery was included in the treatment
pathway, whereas one study recommended at least 3 hours
of fasting.63,64,67 For decades, preoperative fasting was recommended with “NPO after midnight” in an effort to minimize the risk of pulmonary aspiration by decreasing gastric
volume.78 However, over the last several years, this dogma
has been challenged by a multitude of studies demonstrating
preoperative fasting from the intake of clear fluids for 2 hours
and from the intake of solids for 6 hours to be optimal. A 2017
meta-analysis of RCTs demonstrated a lower risk of aspiration for patients with clear liquid intake up to 2 hours prior to
surgery versus traditional fasting (>4 hours).79 Furthermore,
prior systematic reviews concluded that preoperative fasting
to 6 hours for solids is safe.80 The primary concern with prolonged fasting is exacerbation of the surgical stress response,
which constitutes a coordinated reaction to surgical injury.27,81
Ultimately, prolonged catabolism from fasting combined with
the surgical stress response can potentiate hyperglycemia,
insulin resistance, hyperthermia, immunosuppression, and
muscle loss in the perioperative period, potentially contributing to adverse outcomes and delayed recovery.26,27 Therefore,
the goal with perioperative nutritional management is to
mitigate these effects.
In addition to changing fasting guidelines, there is considerable evidence from meta-analyses, systematic reviews, and
RCTs demonstrating the intake of carbohydrate-rich liquids,
ie, carbohydrate loading, prior to elective surgery, reduces
postoperative insulin resistance and hyperglycemia, minimizes muscle loss, and shortens LOS.79,80,82–88 Furthermore,
several RCTs establish clear liquid intake and carbohydrate
loading up to 2 hours before a procedure improves patients’
subjective well-being by reducing thirst and hunger.79,80,86,89–91
Although there are no specific studies in breast reconstruction, evidence-based recommendations can be adapted from
these studies in the elective surgical population.
Recommendation: We recommend minimizing preoperative fasting to only 2 hours for clear liquids and 6 hours for
solids (Grade 1A). Furthermore, we recommend preoperative
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carbohydrate loading via oral liquid intake up to 2 hours
prior to surgery to mitigate adverse effects associated with
the surgical stress response (Grade 1A).

benefit for preoperative showering/bathing with antiseptic
solution; thus, we recommend patients follow usual bathing
practices prior to surgery (Grade 1A).

Antimicrobial prophylaxis

Intraoperative management

All ERAS protocols included preoperative antibiotic use. In
breast reconstruction, evidence for perioperative antibiotics
for the prevention of surgical site infection (SSI) is largely
based on studies in the prosthetic population; data on antibiotic
use in microvascular breast reconstruction are limited. A prior
survey of members of the American Society for Reconstructive Microsurgery (ASRM) revealed consensus agreement
regarding preoperative administration of antibiotics within
1 hour prior to microvascular breast reconstruction; however,
no consensus was present on the optimal duration of antibiotic
administration.92 The practice of administering preoperative
antibiotics within 60 minutes of incision is supported by considerable high-quality evidence, albeit not specific to breast
reconstruction, including a 2014 Cochrane review of RCTs,
and recommended by major national organizations, including
Centers for Disease Control and Prevention (CDC), the Surgical Care Improvement Project (SCIP), and the AHRQ.93–97
What is less clear is the optimal duration of antibiotics. SCIP
and CDC guidelines recommend a short duration (<24 hours)
of prophylaxis.94,95,97 There are two retrospective studies comparing patients receiving 24 versus >24 hours of antimicrobial
prophylaxis in microvascular breast reconstruction.98,99 These
studies showed no reduction in overall incidence of SSI for
patients receiving antibiotics >24 hours. This is also supported
by systematic reviews regarding the duration of prophylactic
antibiotic use in prosthetic breast reconstruction, which presumably has an equal or higher intrinsic risk of SSI due to
the placement of an implant.100,101
One of the ERAS protocols included antiseptic bathing
for antimicrobial prophylaxis. Preoperative bathing and
postoperative bathing with skin antiseptics are often recommended in procedures involving the placement of a prosthesis; however, the prevalence of this practice is unclear.102–104 A
2015 Cochrane review and a 2017 meta-analysis separately
confirmed that there is no clear evidence of benefit for showering/bathing with antiseptic solution compared to usual wash
products prior to clean surgeries.105,106
Recommendation: All patients undergoing breast reconstruction should receive preoperative antibiotics within
1 hour of incision. There is no documented benefit to prolonged antimicrobial prophylaxis; therefore, we recommend
adherence to SCIP and CDC guidelines for administering
only 24 hours of antibiotics (Grade 1A). There is no proven
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Preemptive analgesia and PVBs

The management of postoperative pain with multimodal
therapy is a key component of ERAS protocols. Multimodal
protocols are presumed to be effective because they address
different pain mechanisms to reduce acute postoperative pain,
which may subsequently blunt the development of chronic
pain.27,107 ERAS protocols for breast reconstruction incorporated preemptive analgesia with opioid (at the discretion of the
anesthesia provider) and nonopioid combinations of regional
anesthesia blocks (2/5 studies), nonsteroidal anti-inflammatory
drugs (NSAIDs) (4/5 studies), acetaminophen (5/5 studies),
and/or gabapentin (4/5 studies). Regional anesthesia techniques were previously discussed; NSAIDs, acetaminophen,
and gabapentin are discussed in the postoperative management
section. Local anesthetic techniques utilizing continuous infusion pain catheters and regional anesthetic techniques utilizing
peripheral nerve blocks are described in the literature. A metaanalysis in 2013 demonstrated local anesthetic pain catheters
at the donor site, either on top of the rectus sheath or under
the rectus fascia, significantly decreased opioid use but only
showed a trend toward reducing LOS, for patients undergoing
microvascular breast reconstruction (MBR).108 Furthermore,
two RCTs confirmed that continuous infusion catheters have
no deleterious effect on flap perfusion or complications.109,110
Recommendation: There is moderate quality evidence
to support the inclusion of local anesthetic techniques and
preemptive analgesia in breast reconstruction (Grade 1B).

Perioperative hemodynamics: fluid management,
vasopressors, and allogenic blood transfusions
Perioperative hemodynamics is more relevant to microvascular breast reconstruction compared to prosthetic breast
reconstruction. The goal of perioperative hemodynamic management in microvascular breast reconstruction is to maintain
tissue perfusion and optimize blood flow for the flap.111 A
majority of microsurgeons agree that avoiding intraoperative
hypotension, often considered as a mean arterial pressure
(MAP) of <65 mmHg, is critical to flap success and prefer
some combination of intravenous fluids, blood products, and
vasopressors to achieve this.112 Our understanding of fluid
management has evolved recently, and most ERAS protocols
advocate for either a balanced fluid approach (emphasizing
euvolemia, minimal weight changes, and maintenance of
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normal physiology and homeostasis) or a goal-directed
fluid therapy (GDFT) (emphasizing optimal cardiac output
and oxygen delivery to tissues to prevent hypoperfusion).113
In microvascular breast reconstruction, there is evidence to
support a focus on maintenance of a zero, or near zero, fluid
balance. Data from two retrospective studies demonstrate
that excessive underresuscitation contributes to an increased
risk for adverse flap events.114,115 Similarly, retrospective studies have shown liberal fluid resuscitation or fluid overload
increases flap complications in both breast reconstruction and
other microvascular flap procedures.115–119 In the nonfree flap
population, meta-analyses of RCTs reaffirm the value of balanced fluid therapy in reducing perioperative complications
and LOS.120,121 There are no studies evaluating GDFT, which
uses hemodynamic monitoring to guide fluid management,
in microvascular breast reconstruction. However, multiple
meta-analyses on GDFT in surgical patients demonstrate
reductions in complications and LOS compared to standard
or liberal fluid resuscitation models.122–129 There are no studies
comparing GDFT with balanced fluid therapy.
Although vasopressors were initially presumed to have
devastating effects on free flap success, recent evidence has
not corroborated these fears. A 2014 systematic review of
retrospective studies showed no consistent effects on flap
perfusion or flap complications.130 Subsequent to that publication, a retrospective cohort study of 682 patients and 1039
flaps also failed to demonstrate an increased risk of thrombotic events or flap loss in patients receiving vasopressors.131
In contrast to vasopressors and a balanced fluid approach,
there is evidence suggesting that perioperative allogenic red
blood cell transfusions in microvascular breast reconstruction
are associated with an increased rate of postoperative complications and additional resource utilization. Six retrospective
studies, all published after 2011, concluded that perioperative
transfusions increase postoperative complications, prolong
LOS, and incur additional costs; therefore, restrictive transfusion strategies (avoid transfusions in patients with hemoglobin thresholds >7 g/dL) are now advocated.132–138
Recommendation: Perioperative fluid management should
follow principles of balanced fluid therapy or GDFT and
avoid underresuscitation and/or fluid overload (Grade 1A).
Vasopressors may be used as an adjunct to intravenous fluids
to avoid intraoperative hypotension and maintain hemodynamic stability; to date, human clinical studies have not
demonstrated adverse complications with vasopressor use in
microvascular breast reconstruction, albeit the existing data
are of low quality (Grade 2C). We recommend a restrictive
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strategy for allogenic transfusions to minimize postoperative
complications and avoid prolonged LOS (Grade 1C).

Minimally invasive operative techniques (in
autologous breast reconstruction)
Muscle-sparing procedures (donor-site)
Minimizing the invasiveness of surgical procedures is a key
component of ERAS protocols in different specialties. All
patients treated in the included ERAS protocols for microvascular breast reconstruction underwent either a unilateral
procedure or a bilateral procedure utilizing free TRAM
(FTRAM), muscle-sparing TRAM (MS-TRAM), or DIEP
flaps; there were no superficial inferior epigastric artery
(SIEA) flaps reported. SIEA and DIEP flaps, which theoretically preserve the abdominal wall, would constitute the spectrum of “minimally invasive” surgery when compared with
FTRAM or MS-TRAM flaps or pedicled flaps in autologous
breast reconstruction. In regard to acute recovery, a majority
of the data compares DIEP flaps with TRAM flaps (with MSTRAM and FTRAM often combined into one group). There
are three retrospective studies demonstrating that mean LOS
is shorter in patients undergoing DIEP flaps than in patients
undergoing TRAM flaps.139–141 There is also a single prospective cohort study demonstrating significantly shorter LOS for
SIEA flaps compared with DIEP flaps; however, this study
is limited by inadequate sample size and the lack of control
for comorbidities.142 In regard to long-term postoperative
function, there are multiple meta-analyses of nonrandomized
observational studies comparing donor-site morbidity and
abdominal wall function in patients undergoing MBR with
DIEP, SIEA, or TRAM flaps.143–146 These studies demonstrate
that SIEA and DIEP flaps reduce donor-site morbidity,
including abdominal bulge or hernia, compared to TRAM
flaps but may increase the risk of flap-related complications.
However, there are several methodological limitations to the
studies included in these meta-analyses, which make them
highly susceptible to bias. Interestingly, a recent multicenter
study in North America did not find significant differences
in patient-reported outcomes of abdominal well-being or
morbidity when comparing DIEP flaps with TRAM flaps.147
Recommendation: Surgeons must consider the benefits
of potentially reduced abdominal wall morbidity against the
potential risk of higher complications and the potential burdens of increased operative time and complexity associated
with SIEA and DIEP flaps. We suggest autologous breast
reconstruction be performed with DIEP flaps whenever feasible but acknowledge the decision to perform a SIEA, DIEP,
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MS-TRAM, FTRAM, or pedicled autologous flap, which is
most often dictated by patients’ anatomy and characteristics
(Grade 2B).
Rib-sparing techniques (recipient site)
In addition to donor-site preservation, a less invasive
approach to the recipient site is also advocated in the literature for microvascular breast reconstruction. The presumed
benefit of a rib-sparing approach to internal mammary vessel harvest is diminished chest wall morbidity, whereas the
presumed disadvantages are complexity in patients with
narrow intercostal spaces and limited exposure, which may
lead to operative complications.148 To date, there is lowquality evidence to support rib-sparing techniques. Seven
retrospective studies have been published, most of which
focus on the efficiency and safety of this technique.149–155
Due to substantial heterogeneity, comparison across studies
is limited. Only three studies included a comparison group
(costochondral segment removed) and two of these compared
postoperative pain, both demonstrating significantly reduced
pain with rib preservation.151,153,154 In regard to complications,
most studies had no comparison group but reported a low
incidence of complications in line with acceptable published
standards for breast reconstruction; however, one study did
find a significantly greater incidence of fat necrosis with a
rib-sparing approach.154
Recommendation: There is low-quality evidence to
support rib-sparing techniques in microvascular breast
reconstruction, and substantial uncertainty is present in the
estimates of benefits, risks, and burdens associated with this
technique. Given this, we can only formulate a very weak recommendation that surgeons perform rib-sparing techniques
in patients with suitably wide intercostal spaces; however,
other alternatives may be equally reasonable (Grade 2C).

Prevention of postoperative nausea and vomiting
(PONV)
Avoidance of PONV is frequently identified by patients as
their top priority in the immediate postoperative recovery
period; therefore, the American Society of Anesthesiologists (ASA) recommends prophylaxis for PONV, in addition
to minimize opiate use, in the perioperative period.156–159
There are many agents with antiemetic effects; however,
the best evidence supports 5-HT3 receptor antagonists (eg,
ondansetron), dexamethasone, and transdermal scopolamine.
Data from recent meta-analyses indicate that 5-HT3 receptor
antagonists, dexamethasone, and scopolamine are independently effective at reducing PONV and the need for rescue
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antiemetics when administered prophylactically.159–161 There
are also several RCTs, comparing combination prophylaxis
with multiple agents versus single-agent prophylaxis that
demonstrate a benefit to combination therapy; however, various combinations used and differences in patient populations
precluded pooled analyses.159,162–166
Recommendation: We recommend pharmacological prophylaxis with a combination of antiemetic agents to prevent
PONV and limit the need for rescue treatment (Grade 1A).

Postoperative management
Postoperative analgesia

Minimizing the opiate use is an essential goal in any ERAS
protocol. There is considerable support in the literature for
incorporating NSAIDs, including intravenous ketorolac,
into multimodal analgesia protocols. A Cochrane review of
72 RCTs demonstrated that NSAIDs significantly reduce
postoperative pain compared to placebo.167 Data from three
other meta-analyses also confirm NSAIDs, as a part of multimodal therapy, reduce postoperative pain, and minimize
some adverse effects, including PONV, of opiates in the
postoperative period.168–170 In regard to ketorolac, a metaanalysis of 13 RCTs in a diverse group of surgical patients
found that ketorolac significantly reduced postoperative pain,
opioid consumption, and PONV.171 Recently, Afonso et al63
demonstrated that the addition of intravenous ketorolac to
liposomal bupivacaine TAP blocks significantly reduced
opioid consumption compared to TAP blocks alone in patients
undergoing microvascular breast reconstruction. These findings support a prior retrospective cohort study that found
ketorolac, as an adjunct treatment, reducing opiate use in
TRAM flap breast reconstruction.172 Additionally, bleeding
concerns with the use of ketorolac are not substantiated by
the literature, for either breast reconstruction or surgical
procedures in general.63,170,172,173
In addition to NSAIDs, acetaminophen has been suggested as an adjunct to perioperative pain management
protocols in breast reconstruction. A Cochrane review of 51
RCTs demonstrated that acetaminophen use, compared to
placebo, significantly reduced postoperative pain in surgical
patients.174 Furthermore, a recent systematic review concluded that a combination of acetaminophen and NSAIDs
offers superior analgesia when compared with either drug
alone, lending additional support to the concept of multimodal analgesia protocols.175
Similar to NSAIDs and acetaminophen, gabapentin is
frequently included in ERAS protocols, with the presumed
benefit being the inhibition of nociception and central
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sensitization.176 There are no studies evaluating the independent effect of gabapentin on postoperative pain in breast
reconstruction; however, multiple meta-analyses indicate that
gabapentin has both a significant analgesic and an opioid
sparing effect in surgical patients.176–179
Recommendation: Minimizing the opiate use and postoperative pain is an essential goal of multimodal perioperative care protocols. While minimal direct evidence exists in
breast reconstruction, sufficient high-quality evidence may be
extrapolated to support the inclusion of NSAIDs (ie, ketorolac), acetaminophen, and gabapentin in ERAS protocols to
reduce postoperative pain and opiate use (Grade 1A).

Early ambulation and functional recovery
All of the ERAS protocols included ambulation as a criterion
for discharge, with early mobilization at postoperative day
(POD) 1 emphasized. There are no studies that evaluate the
independent impact of early ambulation on postoperative
outcomes in breast reconstruction and limited studies in the
broader surgical literature. A recent systematic review concluded that there may be some benefit to accelerate bowel
function and reduce hospital LOS with early mobilization in
the abdominal and thoracic surgical populations; however, the
poor methodological quality of included studies and inconsistencies in reporting of outcomes made it difficult to draw any
firm conclusions.180 The primary proposed benefit for early
mobilization is the absence of prolonged immobilization,
which is known to be associated with adverse events, including venous thromboembolism, pulmonary deconditioning,
and muscle weakness.181,182 The risks of early ambulation are
unclear. If patients avoid significant flexion/extension at the
waist, it is hard to identify a theoretical premise for how early
ambulation would potentiate flap or donor-site complications in abdominally based autologous breast reconstruction.
Furthermore, the only burden of early mobilization is the
requirement for physical therapy or nursing assistance until
patients can ambulate independently; however, this requirement is likely present regardless of the date of ambulation.
Recommendation: We recommend early ambulation
be included in ERAS protocols for breast reconstruction.
While there is a lack of high-quality evidence, the potential
benefits appear to outweigh the risks and burdens for early
mobilization (Grade 1C).

Timing of urinary catheter removal
Urinary catheter placement is significantly more common
for lengthy autologous breast reconstruction procedures
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compared to prosthetic procedures. In microvascular breast
reconstruction, all patients typically require urinary catheterization, given the length of surgery and need for resuscitative
monitoring. The timing of catheter removal was a focus in the
published ERAS protocols for microvascular breast reconstruction, with all including removal of urinary catheters at
POD 1 as a protocol item. There is high-quality evidence,
including meta-analyses and RCTs, from the nonmicrovascular surgical literature to support this practice. In general,
these studies have found lower rates of catheter-associated
urinary tract infections and no significantly increased risk of
recatheterization in patients who had early (POD 1) catheter
removal.183–185
Recommendation: We recommend the removal of urinary
catheters by POD 1, at the latest, in all patients undergoing
breast reconstruction who do not require resuscitative monitoring (Grade 1A).

Timing of postoperative nutrition
Similar to the concepts of early mobilization and early
removal of urinary catheters, surgeons in various disciplines
have recommended early postoperative oral feeding (within
24 hours of surgery) to enhance recovery by facilitating
return to normal functioning. Traditionally, patients undergoing prosthetic breast reconstruction were advanced to clear
liquids and then a regular diet as tolerated immediately after
surgery whereas patients undergoing microvascular breast
reconstruction were kept NPO for at least 24 hours as a
precaution in case where emergent return to the operating
room was necessary. As detailed earlier, fasting from oral
liquids does not alter anesthetic risks. Furthermore, given
the low rate of flap complications requiring immediate take
back, this practice of delayed oral intake is unnecessary.
Although no direct evidence exists in breast reconstruction,
there is considerable evidence from the broader surgical
literature that early postoperative oral feeding is beneficial.
Two recent meta-analyses, a 2014 Cochrane review of RCTs
in abdominal gynecological surgery and a 2016 meta-analysis
of 15 studies in gastrointestinal surgery, showed that early
feeding was associated with shorter LOS, higher satisfaction, and no increase in complications when compared with
traditional timing.186,187
Recommendation: For prosthetic reconstruction, we
recommend advancing patients’ diets as tolerated on POD 0.
For microvascular breast reconstruction, we recommend
postoperative oral feeding with clear liquids commencing
immediately postoperatively (POD 0), with intake guided by
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patient preference and comfort. In patients tolerating clear
liquid intake, we advocate advancement to a regular diet on
POD 1 (Grade 1B).
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Discussion and future directions
Increasing health care costs have led to significant health care
reforms and the advent of value-based and alternative payment models that incentivize value, efficiency, and quality in
patient care.22,188 In these new paradigms, it is critical to provide high-quality care while minimizing resource utilization
during an episode of care. In response, ERAS protocols have
been proposed as potential strategies to improve the overall
value of surgical care. While widely utilized in various surgical disciplines, few studies have evaluated ERAS protocols
in breast reconstruction.64 In this study, we comprehensively
reviewed the literature on ERAS protocols for breast reconstruction and provided evidence-based recommendations for
each perioperative intervention included in these protocols.
Although it is promising to start to find ERAS protocols
utilized in breast reconstruction, there remains a paucity of
high-quality evidence on the impact of these protocols. To
date, only five retrospective studies have been published
on ERAS protocols in breast reconstruction and there is a
significant heterogeneity between these studies in regard
to perioperative interventions included, patient groups,
comorbidities reported, and outcomes measured. There
is a substantial need for additional research endeavors on
this topic. It is important that future efforts to develop and
implement ERAS protocols in breast reconstruction follow
evidence-based guidelines in development and clearly report
the components of the protocol. Future RCTs or high-quality
prospective cohort studies are a priority. For studies following
a nonrandomized observational design, patient and treatment
covariates should be reported and controlled for analytically.
Furthermore, studies should report clinically meaningful
outcomes in a standardized way to facilitate comparison.
All studies should, at minimum, report LOS, postoperative
opiate use, and patient-reported outcomes using validated
measures, including QoR and health-related quality of life
(BREAST-Q). Additionally, studies examining the costeffectiveness of ERAS protocols in breast reconstruction are
needed to demonstrate if this intervention has value to the
health care system. Finally, it would be valuable for studies
to identify barriers and enablers to protocol implementation
and provide a detailed description of the implementation
process. Understanding these elements would allow different
institutions to adapt evidence-based protocols to their local
environment.
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Conclusion
Optimizing the perioperative management of patients undergoing microvascular breast reconstruction by implementing
ERAS protocols has the potential to improve postoperative
pain control, enhance patient-centered outcomes, accelerate
recovery, and minimize health care resource utilization. Institutions and surgeons aiming to optimize perioperative care
in MBR should incorporate evidence-based interventions
in the development of future ERAS protocols. Ultimately,
following evidence-based recommendations, as delineated
in this study, is integral to develop and implement treatment
protocols with external validity that improve the quality and
value of patient care.

Acknowledgments
RPP is supported by a National Institutes of Health (NIH)
Ruth L Kirschstein National Research Service Award Institutional Research Training Grant (T32CA190194), the Foundation for Barnes-Jewish Hospital, and a National Cancer
Institute Cancer Center Support Grant to Siteman Cancer
Center (P30 CA091842). The content is solely the responsibility of the authors and does not necessarily represent the
official view of the NIH.

Disclosure
The authors report no conflicts of interest in this work.

References

1. Eltahir Y, Werners LL, Dreise MM, et al. Quality-of-life outcomes
between mastectomy alone and breast reconstruction: comparison of
patient-reported BREAST-Q and other health-related quality-of-life
measures. Plast Reconstr Surg. 2013;132(2):201e–209e.
2. Winters ZE, Benson JR, Pusic AL. A systematic review of the clinical
evidence to guide treatment recommendations in breast reconstruction
based on patient-reported outcome measures and health-related quality
of life. Ann Surg. 2010;252(6):929–942.
3. Matros E, Albornoz CR, Razdan SN, et al. Cost-effectiveness analysis
of implants versus autologous perforator flaps using the BREAST-Q.
Plast Reconstr Surg. 2015;135(4):937–946.
4. Hu ES, Pusic AL, Waljee JF, et al. Patient-reported aesthetic satisfaction
with breast reconstruction during the long-term survivorship period.
Plast Reconstr Surg. 2009;124(1):1–8.
5. Yueh JH, Slavin SA, Adesiyun T, et al. Patient satisfaction in postmastectomy breast reconstruction: a comparative evaluation of DIEP,
TRAM, latissimus flap, and implant techniques. Plast Reconstr Surg.
2010;125(6):1585–1595.
6. Lee KT, Mun GH. Prosthetic breast reconstruction in previously irradiated breasts: a meta-analysis. J Surg Oncol. 2015;112(5):468–475.
7. Pusic AL, Matros E, Fine N, et al. Patient-reported outcomes 1
year after immediate breast reconstruction: results of the mastectomy reconstruction outcomes consortium study. J Clin Oncol.
2017;35(22):2499–2506.
8. Hickey OT, Nugent NF, Burke SM, Hafeez P, Mudrakouski AL,
Shorten GD. Persistent pain after mastectomy with reconstruction.
J Clin Anesth. 2011;23(6):482–488.

Journal of Pain Research 2018:11

Journal of Pain Research downloaded from https://www.dovepress.com/ by 128.252.174.220 on 20-Oct-2018
For personal use only.

Dovepress
9. Vadivelu N, Schreck M, Lopez J, Kodumudi G, Narayan D. Pain after
mastectomy and breast reconstruction. Am Surg. 2008;74(4):285–296.
10. Hickey OT, Burke SM, Hafeez P, Mudrakouski AL, Hayes ID, Shorten
GD. Severity of acute pain after breast surgery is associated with the
likelihood of subsequently developing persistent pain. Clin J Pain.
2010;26(7):556–560.
11. Elmore L, Myckatyn TM, Gao F, et al. Reconstruction patterns in a
single institution cohort of women undergoing mastectomy for breast
cancer. Ann Surg Oncol. 2012;19(10):3223–3229.
12. Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery:
a survey of 282 women. Pain. 1996;66(2–3):195–205.
13. Clarke H, Soneji N, Ko DT, Yun L, Wijeysundera DN. Rates and risk
factors for prolonged opioid use after major surgery: population based
cohort study. BMJ. 2014;348:g1251.
14. Waljee JF, Li L, Brummett CM, Englesbe MJ. Iatrogenic opioid
dependence in the United States: are surgeons the gatekeepers? Ann
Surg. 2016;265(4):728–730.
15. Berg K, Kjellgren K, Unosson M, Arestedt K. Postoperative recovery
and its association with health-related quality of life among day surgery
patients. BMC Nurs. 2012;11(1):24.
16. Joshi GP, Ogunnaike BO. Consequences of inadequate postoperative
pain relief and chronic persistent postoperative pain. Anesthesiol Clin
North America. 2005;23(1):21–36.
17. Wu CL, Richman JM. Postoperative pain and quality of recovery. Curr
Opin Anaesthesiol. 2004;17(5):455–460.
18. Myles PS, Hunt JO, Nightingale CE, et al. Development and psychometric testing of a quality of recovery score after general anesthesia
and surgery in adults. Anesth Analg. 1999;88(1):83–90.
19. Coley KC, Williams BA, DaPos SV, Chen C, Smith RB. Retrospective
evaluation of unanticipated admissions and readmissions after same
day surgery and associated costs. J Clin Anesth. 2002;14(5):349–353.
20. Conway PH. Value-driven health care: implications for hospitals and
hospitalists. J Hosp Med. 2009;4(8):507–511.
21. Miller HD. From volume to value: better ways to pay for health care.
Health Aff (Millwood). 2009;28(5):1418–1428.
22. Porter ME. What is value in health care? N Engl J Med. 2010;363(26):
2477–2481.
23. Lee L, Li C, Landry T, et al. A systematic review of economic evaluations of enhanced recovery pathways for colorectal surgery. Ann Surg.
2014;259(4):670–676.
24. Thiele RH, Rea KM, Turrentine FE, et al. Standardization of care:
impact of an enhanced recovery protocol on length of stay, complications, and direct costs after colorectal surgery. J Am Coll Surg.
2015;220(4):430–443.
25. Shewale JB, Correa AM, Baker CM, et al; University of Texas MD
Anderson Esophageal Cancer Collaborative Group. Impact of a fasttrack esophagectomy protocol on esophageal cancer patient outcomes
and hospital charges. Ann Surg. 2015;261(6):1114–1123.
26. Wilmore DW. From Cuthbertson to fast-track surgery: 70 years
of progress in reducing stress in surgical patients. Ann Surg.
2002;236(5):643–648.
27. Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet. 2003;362(9399):1921–1928.
28. Kehlet H, Jorgensen CC. Advancing surgical outcomes research and
quality improvement within an enhanced recovery program framework.
Ann Surg. 2016;264(2):237–238.
29. Arsalani-Zadeh R, ElFadl D, Yassin N, MacFie J. Evidence-based
review of enhancing postoperative recovery after breast surgery. Br J
Surg. 2011;98(2):181–196.
30. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items
for systematic reviews and meta-analyses: the PRISMA statement.
PLoS Med. 2009;6(7):e1000097.
31. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational
studies in epidemiology: a proposal for reporting. Meta-analysis Of
Observational Studies in Epidemiology (MOOSE) group. JAMA.
2000;283(15):2008–2012.

Journal of Pain Research 2018:11

Pain management in breast reconstruction
32. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group.
GRADE: an emerging consensus on rating quality of evidence and
strength of recommendations. BMJ. 2008;336(7650):924–926.
33. Guyatt GH, Oxman AD, Kunz R, et al; GRADE Working Group. Going
from evidence to recommendations. BMJ. 2008;336(7652):1049–1051.
34. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of
recommendations and quality of evidence in clinical guidelines: report
from an American College of Chest Physicians task force. Chest.
2006;129(1):174–181.
35. Ariyan S, Martin J, Lal A, et al. Antibiotic prophylaxis for preventing
surgical-site infection in plastic surgery: an evidence-based consensus conference statement from the American Association of Plastic
Surgeons. Plast Reconstr Surg. 2015;135(6):1723–1739.
36. Pannucci CJ, MacDonald JK, Ariyan S, et al. Benefits and risks of prophylaxis for deep venous thrombosis and pulmonary embolus in plastic
surgery: a systematic review and meta-analysis of controlled trials and
consensus conference. Plast Reconstr Surg. 2016;137(2):709–730.
37. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic
Reviews of Interventions Version 5.1.0 [updated March 2011]. The
Cochrane Collaboration, 2011.
38. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A.
GRADE guidelines: a new series of articles in the Journal of Clinical
Epidemiology. J Clin Epidemiol. 2011;64(4):380–382.
39. Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines: 3.
Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–406.
40. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
J Clin Epidemiol. 2011;64(4):383–394.
41. Kumar K, Kirksey MA, Duong S, Wu CL. A review of opioid-sparing
modalities in perioperative pain management: methods to decrease
opioid use postoperatively. Anesth Analg. 2017;125(5):1749–1760.
42. Baxter R, Bramlett K, Onel E, Daniels S. Impact of local administration
of liposome bupivacaine for postsurgical analgesia on wound healing:
a review of data from ten prospective, controlled clinical studies. Clin
Ther. 2013;35(3):312–320.e5.
43. Vyas KS, Rajendran S, Morrison SD, et al. Systematic review of
liposomal bupivacaine (exparel) for postoperative analgesia. Plast
Reconstr Surg. 2016;138(4):748e–756e.
44. Rafi AN. Abdominal field block: a new approach via the lumbar
triangle. Anaesthesia. 2001;56(10):1024–1026.
45. Charlton S, Cyna AM, Middleton P, Griffiths JD. Perioperative transversus abdominis plane (TAP) blocks for analgesia after abdominal
surgery. Cochrane Database Syst Rev. 2010;12:CD007705.
46. Hivelin M, Wyniecki A, Plaud B, Marty J, Lantieri L. Ultrasoundguided bilateral transversus abdominis plane block for postoperative
analgesia after breast reconstruction by DIEP flap. Plast Reconstr
Surg. 2011;128(1):44–55.
47. Zhong T, Ojha M, Bagher S, et al. Transversus abdominis plane block
reduces morphine consumption in the early postoperative period
following microsurgical abdominal tissue breast reconstruction: a
double-blind, placebo-controlled, randomized trial. Plast Reconstr
Surg. 2014;134(5):870–878.
48. Zhong T, Wong KW, Cheng H, et al. Transversus abdominis plane
(TAP) catheters inserted under direct vision in the donor site following free DIEP and MS-TRAM breast reconstruction: a prospective cohort study of 45 patients. J Plast Reconstr Aesthet Surg.
2013;66(3):329–336.
49. Wheble GA, Tan EK, Turner M, Durrant CA, Heppell S. Surgeonadministered, intra-operative transversus abdominis plane block in
autologous breast reconstruction: a UK hospital experience. J Plast
Reconstr Aesthet Surg. 2013;66(12):1665–1670.
50. Jablonka EM, Lamelas AM, Kim JN, et al. Transversus abdominis
plane blocks with single-dose liposomal bupivacaine in conjunction
with a nonnarcotic pain regimen help reduce length of stay following
abdominally based microsurgical breast reconstruction. Plast Reconstr
Surg. 2017;140(2):240–251.

submit your manuscript | www.dovepress.com

Dovepress

Powered by TCPDF (www.tcpdf.org)

1577

Journal of Pain Research downloaded from https://www.dovepress.com/ by 128.252.174.220 on 20-Oct-2018
For personal use only.

Parikh and Myckatyn
51. Rozen WM, Tran TM, Ashton MW, Barrington MJ, Ivanusic JJ, Taylor
GI. Refining the course of the thoracolumbar nerves: a new understanding of the innervation of the anterior abdominal wall. Clin Anat.
2008;21(4):325–333.
52. Jankovic ZB, du Feu FM, McConnell P. An anatomical study of
the transversus abdominis plane block: location of the lumbar
triangle of Petit and adjacent nerves. Anesth Analg. 2009;109(3):
981–985.
53. Schnabel A, Reichl SU, Kranke P, Pogatzki-Zahn EM, Zahn PK.
Efficacy and safety of paravertebral blocks in breast surgery:
a meta-analysis of randomized controlled trials. Br J Anaesth.
2010;105(6):842–852.
54. Parikh RP, Sharma K, Guffey R, Myckatyn TM. Preoperative paravertebral block improves postoperative pain control and reduces
hospital length of stay in patients undergoing autologous breast
reconstruction after mastectomy for breast cancer. Ann Surg Oncol.
2016;23(13):4262–4269.
55. Odom EB, Mehta N, Parikh RP, Guffey R, Myckatyn TM. Paravertebral blocks reduce narcotic use without affecting perfusion in
patients undergoing autologous breast reconstruction. Ann Surg Oncol.
2017;24(11):3180–3187.
56. Unkart JT, Padwal JA, Ilfeld BM, Wallace AM. Treatment of postlatissimus dorsi flap breast reconstruction pain with continuous
paravertebral nerve blocks: a retrospective review. Anesth Pain Med.
2016;6(5):e39476.
57. Coopey SB, Specht MC, Warren L, Smith BL, Winograd JM, Fleischmann K. Use of preoperative paravertebral block decreases length of
stay in patients undergoing mastectomy plus immediate reconstruction.
Ann Surg Oncol. 2013;20(4):1282–1286.
58. Fahy AS, Jakub JW, Dy BM, et al. Paravertebral blocks in patients
undergoing mastectomy with or without immediate reconstruction
provides improved pain control and decreased postoperative nausea
and vomiting. Ann Surg Oncol. 2014;21(10):3284–3289.
59. Glissmeyer C, Johnson W, Sherman B, Glissmeyer M, Garreau J,
Johnson N. Effect of paravertebral nerve blocks on narcotic use after
mastectomy with reconstruction. Am J Surg. 2015;209(5):881–883.
60. Wolf O, Clemens MW, Purugganan RV, et al. A prospective, randomized, controlled trial of paravertebral block versus general anesthesia
alone for prosthetic breast reconstruction. Plast Reconstr Surg.
2016;137(4):660e–666e.
61. Pace MM, Sharma B, Anderson-Dam J, Fleischmann K, Warren L,
Stefanovich P. Ultrasound-guided thoracic paravertebral blockade: a
retrospective study of the incidence of complications. Anesth Analg.
2016;122(4):1186–1191.
62. Krediet AC, Moayeri N, van Geffen GJ, et al. Different approaches to
ultrasound-guided thoracic paravertebral block: an illustrated review.
Anesthesiology. 2015;123(2):459–474.
63. Afonso A, Oskar S, Tan KS, et al. Is enhanced recovery the new standard of care in microsurgical breast reconstruction? Plast Reconstr
Surg. 2017;139(5):1053–1061.
64. Batdorf NJ, Lemaine V, Lovely JK, et al. Enhanced recovery after surgery in microvascular breast reconstruction. J Plast Reconstr Aesthet
Surg. 2015;68(3):395–402.
65. Bonde C, Khorasani H, Eriksen K, Wolthers M, Kehlet H, Elberg J.
Introducing the fast track surgery principles can reduce length of stay
after autologous breast reconstruction using free flaps: a case control
study. J Plast Surg Hand Surg. 2015;49(6):367–371.
66. Bonde CT, Khorasani H, Elberg J, Kehlet H. Perioperative optimization of autologous breast reconstruction. Plast Reconstr Surg.
2016;137(2):411–414.
67. Dumestre DO, Webb CE, Temple-Oberle C. Improved recovery
experience achieved for women undergoing implant-based breast
reconstruction using an enhanced recovery after surgery model. Plast
Reconstr Surg. 2017;139(3):550–559.
68. Barry MJ, Edgman-Levitan S. Shared decision making – pinnacle of
patient-centered care. N Engl J Med. 2012;366(9):780–781.

1578

Powered by TCPDF (www.tcpdf.org)

submit your manuscript | www.dovepress.com

Dovepress

Dovepress
69. Braddock CH 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson
W. Informed decision making in outpatient practice: time to get back
to basics. JAMA. 1999;282(24):2313–2320.
70. Cohen WA, Ballard TN, Hamill JB, et al. Understanding and optimizing the patient experience in breast reconstruction. Ann Plast Surg.
2016;77(2):237–241.
71. Ho AL, Klassen AF, Cano S, Scott AM, Pusic AL. Optimizing patientcentered care in breast reconstruction: the importance of preoperative
information and patient-physician communication. Plast Reconstr
Surg. 2013;132(2):212e–220e.
72. Liu C, Zhuang Y, Momeni A, et al. Quality of life and patient satisfaction after microsurgical abdominal flap versus staged expander/implant
breast reconstruction: a critical study of unilateral immediate breast
reconstruction using patient-reported outcomes instrument BREASTQ. Breast Cancer Res Treat. 2014;146(1):117–126.
73. Sheehan J, Sherman KA, Lam T, Boyages J. Association of information
satisfaction, psychological distress and monitoring coping style with
post-decision regret following breast reconstruction. Psychooncology.
2007;16(4):342–351.
74. Zhong T, Hu J, Bagher S, et al. Decision regret following breast reconstruction: the role of self-efficacy and satisfaction with information in
the preoperative period. Plast Reconstr Surg. 2013;132(5):724e–734e.
75. Aarts MA, Okrainec A, Glicksman A, Pearsall E, Victor JC, McLeod
RS. Adoption of enhanced recovery after surgery (ERAS) strategies
for colorectal surgery at academic teaching hospitals and impact on
total length of hospital stay. Surg Endosc. 2012;26(2):442–450.
76. Forsmo HM, Pfeffer F, Rasdal A, Sintonen H, Korner H, Erichsen
C. Pre- and postoperative stoma education and guidance within an
enhanced recovery after surgery (ERAS) programme reduces length
of hospital stay in colorectal surgery. Int J Surg. 2016;36(pt A):
121–126.
77. Younis J, Salerno G, Fanto D, Hadjipavlou M, Chellar D, Trickett
JP. Focused preoperative patient stoma education, prior to ileostomy
formation after anterior resection, contributes to a reduction in delayed
discharge within the enhanced recovery programme. Int J Colorectal
Dis. 2012;27(1):43–47.
78. Maltby JR. Fasting from midnight – the history behind the dogma.
Best Pract Res Clin Anaesthesiol. 2006;20(3):363–378.
79. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application
to healthy patients undergoing elective procedures: an updated report
by the American Society of Anesthesiologists task force on preoperative fasting and the use of pharmacologic agents to reduce the risk of
pulmonary aspiration. Anesthesiology. 2017;126(3):376–393.
80. Brady M, Kinn S, Stuart P. Preoperative fasting for adults to prevent perioperative complications. Cochrane Database Syst Rev.
2003;4:CD004423.
81. Blomqvist L, Malm M, Berg A, Svelander L, Kleinau S. The inflammatory reaction in elective flap surgery. Plast Reconstr Surg. 1998;101(6):
1524–1528.
82. Lambert E, Carey S. Practice guideline recommendations on perioperative fasting: a systematic review. JPEN J Parenter Enteral Nutr.
2016;40(8):1158–1165.
83. Li L, Wang Z, Ying X, et al. Preoperative carbohydrate loading for
elective surgery: a systematic review and meta-analysis. Surg Today.
2012;42(7):613–624.
84. Noblett SE, Watson DS, Huong H, Davison B, Hainsworth PJ, Horgan
AF. Pre-operative oral carbohydrate loading in colorectal surgery: a
randomized controlled trial. Colorectal Dis. 2006;8(7):563–569.
85. Smith I, Kranke P, Murat I, et al; European Society of Anaesthesiology. Perioperative fasting in adults and children: guidelines
from the European Society of Anaesthesiology. Eur J Anaesthesiol.
2011;28(8):556–569.
86. Smith MD, McCall J, Plank L, Herbison GP, Soop M, Nygren J. Preoperative carbohydrate treatment for enhancing recovery after elective
surgery. Cochrane Database Syst Rev. 2014;8:CD009161.

Journal of Pain Research 2018:11

Journal of Pain Research downloaded from https://www.dovepress.com/ by 128.252.174.220 on 20-Oct-2018
For personal use only.

Dovepress
87. Yagci G, Can MF, Ozturk E, et al. Effects of preoperative carbohydrate loading on glucose metabolism and gastric contents in patients
undergoing moderate surgery: a randomized, controlled trial. Nutrition.
2008;24(3):212–216.
88. Yuill KA, Richardson RA, Davidson HI, Garden OJ, Parks RW.
The administration of an oral carbohydrate-containing fluid prior
to major elective upper-gastrointestinal surgery preserves skeletal
muscle mass postoperatively – a randomised clinical trial. Clin Nutr.
2005;24(1):32–37.
89. Gilbert SS, Easy WR, Fitch WW. The effect of pre-operative oral fluids
on morbidity following anaesthesia for minor surgery. Anaesthesia.
1995;50(1):79–81.
90. Goodwin AP, Rowe WL, Ogg TW, Samaan A. Oral fluids prior to
day surgery. The effect of shortening the pre-operative fluid fast on
postoperative morbidity. Anaesthesia. 1991;46(12):1066–1068.
91. Wang ZG, Wang Q, Wang WJ, Qin HL. Randomized clinical trial to
compare the effects of preoperative oral carbohydrate versus placebo
on insulin resistance after colorectal surgery. Br J Surg. 2010;97(3):
317–327.
92. Reiffel AJ, Kamdar MR, Kadouch DJ, Rohde CH, Spector JA. Perioperative antibiotics in the setting of microvascular free tissue transfer:
current practices. J Reconstr Microsurg. 2010;26(6):401–407.
93. Jones DJ, Bunn F, Bell-Syer SV. Prophylactic antibiotics to prevent
surgical site infection after breast cancer surgery. Cochrane Database
Syst Rev. 2014;3:CD005360.
94. Bratzler DW, Dellinger EP, Olsen KM, et al; American Society of
Health-System Pharmacists; Infectious Disease Society of America;
Surgical Infection Society; Society for Healthcare Epidemiology of
America. Clinical practice guidelines for antimicrobial prophylaxis
in surgery. Am J Health Syst Pharm. 2013;70(3):195–283.
95. Bratzler DW, Houck PM; Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory
statement from the National Surgical Infection Prevention Project.
Am J Surg. 2005;189(4):395–404.
96. Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society
of America. Clin Infect Dis. 1994;18(3):422–427.
97. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline
for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol.
1999;20(4):250–278; quiz 279–280.
98. Drury KE, Lanier ST, Khavanin N, et al. Impact of postoperative
antibiotic prophylaxis duration on surgical site infections in autologous
breast reconstruction. Ann Plast Surg. 2016;76(2):174–179.
99. Liu DZ, Dubbins JA, Louie O, Said HK, Neligan PC, Mathes DW.
Duration of antibiotics after microsurgical breast reconstruction does not
change surgical infection rate. Plast Reconstr Surg. 2012;129(2):362–367.
100. Phillips BT, Halvorson EG. Antibiotic prophylaxis following implantbased breast reconstruction: what is the evidence? Plast Reconstr Surg.
2016;138(4):751–757.
101. Wang F, Chin R, Piper M, Esserman L, Sbitany H. Do prolonged
prophylactic antibiotics reduce the incidence of surgical-site infections
in immediate prosthetic breast reconstruction? Plast Reconstr Surg.
2016;138(6):1141–1149.
102. Brahmbhatt RD, Huebner M, Scow JS, et al. National practice patterns in preoperative and postoperative antibiotic prophylaxis in breast
procedures requiring drains: survey of the American Society of Breast
Surgeons. Ann Surg Oncol. 2012;19(10):3205–3211.
103. Craft RO, Damjanovic B, Colwell AS. Evidence-based protocol for
infection control in immediate implant-based breast reconstruction.
Ann Plast Surg. 2012;69(4):446–450.
104. Gowda AU, Chopra K, Brown EN, Slezak S, Rasko Y. Preventing breast
implant contamination in breast reconstruction: a national survey of
current practice. Ann Plast Surg. 2017;78(2):153–156.
105. Franco LM, Cota GF, Pinto TS, Ercole FF. Preoperative bathing of the
surgical site with chlorhexidine for infection prevention: systematic
review with meta-analysis. Am J Infect Control. 2017;45(4):343–349.

Journal of Pain Research 2018:11

Pain management in breast reconstruction
106. Webster J, Osborne S. Preoperative bathing or showering with skin
antiseptics to prevent surgical site infection. Cochrane Database Syst
Rev. 2015;2:CD004985.
107. Moiniche S, Kehlet H, Dahl JB. A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief:
the role of timing of analgesia. Anesthesiology. 2002;96(3):725–741.
108. Giordano S, Verajankorva E, Koskivuo I, Suominen E. Effectiveness of local
anaesthetic pain catheters for abdominal donor site analgesia in patients
undergoing free lower abdominal flap breast reconstruction: a meta-analysis
of comparative studies. J Plast Surg Hand Surg. 2013;47(6):428–433.
109. Heller L, Kowalski AM, Wei C, Butler CE. Prospective, randomized, double-blind trial of local anesthetic infusion and intravenous
narcotic patient-controlled anesthesia pump for pain management
after free TRAM flap breast reconstruction. Plast Reconstr Surg.
2008;122(4):1010–1018.
110. Dagtekin O, Hotz A, Kampe S, Auweiler M, Warm M. Postoperative
analgesia and flap perfusion after pedicled TRAM flap reconstruction
– continuous wound instillation with ropivacaine 0.2%. A pilot study.
J Plast Reconstr Aesthet Surg. 2009;62(5):618–625.
111. Hagau N, Longrois D. Anesthesia for free vascularized tissue transfer.
Microsurgery. 2009;29(2):161–167.
112. Vyas K, Wong L. Intraoperative management of free flaps: current
practice. Ann Plast Surg. 2014;72(6):S220–S223.
113. Thiele RH, Raghunathan K, Brudney CS, et al; Perioperative Quality Initiative (POQI) I Workgroup. American Society for Enhanced
Recovery (ASER) and Perioperative Quality Initiative (POQI) joint
consensus statement on perioperative fluid management within an
enhanced recovery pathway for colorectal surgery. Perioper Med
(Lond). 2016;5:24.
114. Nelson JA, Fischer JP, Grover R, et al. Intraoperative perfusion management impacts postoperative outcomes: an analysis of 682 autologous
breast reconstruction patients. J Plast Reconstr Aesthet Surg. 2015;68(2):
175–183.
115. Zhong T, Neinstein R, Massey C, et al. Intravenous fluid infusion rate
in microsurgical breast reconstruction: important lessons learned from
354 free flaps. Plast Reconstr Surg. 2011;128(6):1153–1160.
116. Booi DI. Perioperative fluid overload increases anastomosis thrombosis
in the free TRAM flap used for breast reconstruction. Eur J Plast Surg.
2011;34(2):81–86.
117. Clark JR, McCluskey SA, Hall F, et al. Predictors of morbidity following free flap reconstruction for cancer of the head and neck. Head
Neck. 2007;29(12):1090–1101.
118. Haughey BH, Wilson E, Kluwe L, et al. Free flap reconstruction of the
head and neck: analysis of 241 cases. Otolaryngol Head Neck Surg.
2001;125(1):10–17.
119. Patel RS, McCluskey SA, Goldstein DP, et al. Clinicopathologic and
therapeutic risk factors for perioperative complications and prolonged
hospital stay in free flap reconstruction of the head and neck. Head
Neck. 2010;32(10):1345–1353.
120. Jia FJ, Yan QY, Sun Q, Tuxun T, Liu H, Shao L. Liberal versus restrictive fluid management in abdominal surgery: a meta-analysis. Surg
Today. 2017;47(3):344–356.
121. Varadhan KK, Lobo DN. A meta-analysis of randomised controlled
trials of intravenous fluid therapy in major elective open abdominal surgery: getting the balance right. Proc Nutr Soc. 2010;69(4):
488–498.
122. Berger MM, Gradwohl-Matis I, Brunauer A, Ulmer H, Dunser MW.
Targets of perioperative fluid therapy and their effects on postoperative
outcome: a systematic review and meta-analysis. Minerva Anestesiol.
2015;81(7):794–808.
123. Corcoran T, Rhodes JE, Clarke S, Myles PS, Ho KM. Perioperative
fluid management strategies in major surgery: a stratified metaanalysis. Anesth Analg. 2012;114(3):640–651.
124. Giglio MT, Marucci M, Testini M, Brienza N. Goal-directed haemodynamic therapy and gastrointestinal complications in major
surgery: a meta-analysis of randomized controlled trials. Br J Anaesth.
2009;103(5):637–646.

submit your manuscript | www.dovepress.com

Dovepress

Powered by TCPDF (www.tcpdf.org)

1579

Journal of Pain Research downloaded from https://www.dovepress.com/ by 128.252.174.220 on 20-Oct-2018
For personal use only.

Parikh and Myckatyn
125. Li P, Qu LP, Qi D, et al. Significance of perioperative goal-directed
hemodynamic approach in preventing postoperative complications in
patients after cardiac surgery: a meta-analysis and systematic review.
Ann Med. 2017;49(4):343–351.
126. Ripolles-Melchor J, Espinosa A, Martinez-Hurtado E, et al. Perioperative goal-directed hemodynamic therapy in noncardiac surgery: a
systematic review and meta-analysis. J Clin Anesth. 2016;28:105–115.
127. Rollins KE, Lobo DN. Intraoperative goal-directed fluid therapy in
elective major abdominal surgery: a meta-analysis of randomized
controlled trials. Ann Surg. 2016;263(3):465–476.
128. Som A, Maitra S, Bhattacharjee S, Baidya DK. Goal directed fluid
therapy decreases postoperative morbidity but not mortality in major
non-cardiac surgery: a meta-analysis and trial sequential analysis of
randomized controlled trials. J Anesth. 2017;31(1):66–81.
129. Yuan J, Sun Y, Pan C, Li T. Goal-directed fluid therapy for reducing risk
of surgical site infections following abdominal surgery – a systematic
review and meta-analysis of randomized controlled trials. Int J Surg.
2017;39:74–87.
130. Ibrahim AM, Kim PS, Rabie AN, Lee BT, Lin SJ. Vasopressors and
reconstructive flap perfusion: a review of the literature comparing the effects of various pharmacologic agents. Ann Plast Surg.
2014;73(2):245–248.
131. Nelson JA, Fischer JP, Grover R, et al. Intraoperative vasopressors and
thrombotic complications in free flap breast reconstruction. J Plast
Surg Hand Surg. 2017;51(5):336–341.
132. Appleton SE, Ngan A, Kent B, Morris SF. Risk factors influencing
transfusion rates in DIEP flap breast reconstruction. Plast Reconstr
Surg. 2011;127(5):1773–1782.
133. Fischer JP, Nelson JA, Au A, Tuggle CT 3rd, Serletti JM, Wu LC.
Complications and morbidity following breast reconstruction – a
review of 16,063 cases from the 2005-2010 NSQIP datasets. J Plast
Surg Hand Surg. 2014;48(2):104–114.
134. Fischer JP, Nelson JA, Sieber B, et al. Transfusions in autologous breast
reconstructions: an analysis of risk factors, complications, and cost.
Ann Plast Surg. 2014;72(5):566–571.
135. Lee HK, Kim DH, Jin US, Jeon YT, Hwang JW, Park HP. Effect of perioperative transfusion of old red blood cells on postoperative complications
after free muscle sparing transverse rectus abdominis myocutaneous flap
surgery for breast reconstruction. Microsurgery. 2014;34(6):434–438.
136. Lymperopoulos NS, Sofos S, Constantinides J, Koshy O, Graham
K. Blood loss and transfusion rates in DIEP flap breast reconstruction. Introducing a new predictor. J Plast Reconstr Aesthet Surg.
2013;66(12):1659–1664.
137. Macdonald CR, Reeve W, Hazari A. The use of blood products in free
flap based breast reconstruction: a cost and safety analysis. J Plast
Reconstr Aesthet Surg. 2014;67(5):732–733.
138. O’Neill AC, Barandun M, Cha J, Zhong T, Hofer SO. Restrictive use
of perioperative blood transfusion does not increase complication rates
in microvascular breast reconstruction. J Plast Reconstr Aesthet Surg.
2016;69(8):1092–1096.
139. Kroll SS, Sharma S, Koutz C, et al. Postoperative morphine
requirements of free TRAM and DIEP flaps. Plast Reconstr Surg.
2001;107(2):338–341.
140. Vega SJ, Bossert RP, Serletti JM. Improving outcomes in bilateral
breast reconstruction using autogenous tissue. Ann Plast Surg.
2006;56(5):487–490; discussion 490–481.
141. Zoghbi Y, Gerth DJ, Tashiro J, Golpanian S, Thaller SR. Deep inferior
epigastric perforator versus free transverse rectus abdominis myocutaneous flap: complications and resource utilization. Ann Plast Surg.
2017;78(5):516–520.
142. Chevray PM. Breast reconstruction with superficial inferior epigastric
artery flaps: a prospective comparison with TRAM and DIEP flaps.
Plast Reconstr Surg. 2004;114(5):1077–1083; discussion 1084–1075.
143. Atisha D, Alderman AK. A systematic review of abdominal wall function following abdominal flaps for postmastectomy breast reconstruction. Ann Plast Surg. 2009;63(2):222–230.

1580

Powered by TCPDF (www.tcpdf.org)

submit your manuscript | www.dovepress.com

Dovepress

Dovepress
144. Egeberg A, Rasmussen MK, Sorensen JA. Comparing the donor-site
morbidity using DIEP, SIEA or MS-TRAM flaps for breast reconstructive surgery: a meta-analysis. J Plast Reconstr Aesthet Surg.
2012;65(11):1474–1480.
145. Man LX, Selber JC, Serletti JM. Abdominal wall following free TRAM
or DIEP flap reconstruction: a meta-analysis and critical review. Plast
Reconstr Surg. 2009;124(3):752–764.
146. Wang XL, Liu LB, Song FM, Wang QY. Meta-analysis of the safety
and factors contributing to complications of MS-TRAM, DIEP,
and SIEA flaps for breast reconstruction. Aesthetic Plast Surg.
2014;38(4):681–691.
147. Macadam SA, Zhong T, Weichman K, et al. Quality of life and patientreported outcomes in breast cancer survivors: a multicenter comparison
of four abdominally based autologous reconstruction methods. Plast
Reconstr Surg. 2016;137(3):758–771.
148. Mosahebi A, Da Lio A, Mehrara BJ. The use of a pectoralis major flap
to improve internal mammary vessels exposure and reduce contour
deformity in microvascular free flap breast reconstruction. Ann Plast
Surg. 2008;61(1):30–34.
149. Darcy CM, Smit JM, Audolfsson T, Acosta R. Surgical technique: the
intercostal space approach to the internal mammary vessels in 463
microvascular breast reconstructions. J Plast Reconstr Aesthet Surg.
2011;64(1):58–62.
150. Kim H, Lim SY, Pyon JK, et al. Rib-sparing and internal mammary
artery-preserving microsurgical breast reconstruction with the free
DIEP flap. Plast Reconstr Surg. 2013;131(3):327e–334e.
151. Mickute Z, Di Candia M, Moses M, Bailey AR, Malata CM. Analgesia
requirements in patients undergoing DIEP flap breast reconstructions:
rib preservation versus rib sacrifice. J Plast Reconstr Aesthet Surg.
2010;63(12):e837–e839.
152. Parrett BM, Caterson SA, Tobias AM, Lee BT. The rib-sparing technique for internal mammary vessel exposure in microsurgical breast
reconstruction. Ann Plast Surg. 2008;60(3):241–243.
153. Sacks JM, Chang DW. Rib-sparing internal mammary vessel harvest
for microvascular breast reconstruction in 100 consecutive cases. Plast
Reconstr Surg. 2009;123(5):1403–1407.
154. Wilson S, Weichman K, Broer PN, et al. To resect or not to resect:
the effects of rib-sparing harvest of the internal mammary vessels in
microsurgical breast reconstruction. J Reconstr Microsurg. 2016;32(2):
94–100.
155. Zeng A, Zhu L, Liu Z, et al. [Rib-sparing technique for internal mammary vessels exposure and anastomosis in breast reconstruction with
deep inferior epigastric perforator flap]. Zhongguo Xiu Fu Chong Jian
Wai Ke Za Zhi. 2014;28(11):1376–1379.
156. Eberhart LH, Morin AM, Wulf H, Geldner G. Patient preferences
for immediate postoperative recovery. Br J Anaesth. 2002;89(5):
760–761.
157. Lee A, Gin T, Lau AS, Ng FF. A comparison of patients’ and health
care professionals’ preferences for symptoms during immediate postoperative recovery and the management of postoperative nausea and
vomiting. Anesth Analg. 2005;100(1):87–93.
158. Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia
outcomes are important to avoid? The perspective of patients. Anesth
Analg. 1999;89(3):652–658.
159. Apfelbaum JL, Silverstein JH, Chung FF, et al; American Society of
Anesthesiologists Task Force on Postanesthetic Care. Practice guidelines for postanesthetic care: an updated report by the American Society
of Anesthesiologists task force on postanesthetic care. Anesthesiology.
2013;118(2):291–307.
160. De Oliveira GS Jr, Castro-Alves LJ, Ahmad S, Kendall MC, McCarthy
RJ. Dexamethasone to prevent postoperative nausea and vomiting: an
updated meta-analysis of randomized controlled trials. Anesth Analg.
2013;116(1):58–74.
161. Apfel CC, Zhang K, George E, et al. Transdermal scopolamine for the
prevention of postoperative nausea and vomiting: a systematic review
and meta-analysis. Clin Ther. 2010;32(12):1987–2002.

Journal of Pain Research 2018:11

Journal of Pain Research downloaded from https://www.dovepress.com/ by 128.252.174.220 on 20-Oct-2018
For personal use only.

Dovepress
162. Gan TJ, Sinha AC, Kovac AL, et al; TDS Study Group. A randomized,
double-blind, multicenter trial comparing transdermal scopolamine
plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Anesth Analg.
2009;108(5):1498–1504.
163. Sah N, Ramesh V, Kaul B, Dalby P, Shestak K, Vallejo MC. Transdermal scopolamine patch in addition to ondansetron for postoperative
nausea and vomiting prophylaxis in patients undergoing ambulatory
cosmetic surgery. J Clin Anesth. 2009;21(4):249–252.
164. Jones S, Strobl R, Crosby D, Burkard JF, Maye J, Pellegrini JE. The
effect of transdermal scopolamine on the incidence and severity of
postoperative nausea and vomiting in a group of high-risk patients
given prophylactic intravenous ondansetron. AANA J. 2006;74(2):
127–132.
165. Awad IT, Murphy D, Stack D, Swanton BJ, Meeke RI, Shorten GD. A
comparison of the effects of droperidol and the combination of droperidol and ondansetron on postoperative nausea and vomiting for patients
undergoing laparoscopic cholecystectomy. J Clin Anesth. 2002;14(7):
481–485.
166. Carlisle JB, Stevenson CA. Drugs for preventing postoperative nausea
and vomiting. Cochrane Database Syst Rev. 2006;3:CD004125.
167. Derry C, Derry S, Moore RA, McQuay HJ. Single dose oral ibuprofen
for acute postoperative pain in adults. Cochrane Database Syst Rev.
2009;3:CD001548.
168. Elia N, Lysakowski C, Tramer MR. Does multimodal analgesia with
acetaminophen, nonsteroidal antiinflammatory drugs, or selective
cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine
offer advantages over morphine alone? Meta-analyses of randomized
trials. Anesthesiology. 2005;103(6):1296–1304.
169. Marret E, Kurdi O, Zufferey P, Bonnet F. Effects of nonsteroidal
antiinflammatory drugs on patient-controlled analgesia morphine side
effects: meta-analysis of randomized controlled trials. Anesthesiology.
2005;102(6):1249–1260.
170. Kelley BP, Bennett KG, Chung KC, Kozlow JH. Ibuprofen may not
increase bleeding risk in plastic surgery: a systematic review and
meta-analysis. Plast Reconstr Surg. 2016;137(4):1309–1316.
171. De Oliveira GS Jr, Agarwal D, Benzon HT. Perioperative single dose
ketorolac to prevent postoperative pain: a meta-analysis of randomized
trials. Anesth Analg. 2012;114(2):424–433.
172. Sharma S, Chang DW, Koutz C, et al. Incidence of hematoma associated with ketorolac after TRAM flap breast reconstruction. Plast
Reconstr Surg. 2001;107(2):352–355.
173. Stephens DM, Richards BG, Schleicher WF, Zins JE, Langstein HN.
Is ketorolac safe to use in plastic surgery? A critical review. Aesthet
Surg J. 2015;35(4):462–466.
174. Toms L, McQuay HJ, Derry S, Moore RA. Single dose oral paracetamol
(acetaminophen) for postoperative pain in adults. Cochrane Database
Syst Rev. 2008;4:CD004602.

Journal of Pain Research

Publish your work in this journal
The Journal of Pain Research is an international, peer reviewed, open
access, online journal that welcomes laboratory and clinical findings
in the fields of pain research and the prevention and management
of pain. Original research, reviews, symposium reports, hypothesis formation and commentaries are all considered for publication.

Pain management in breast reconstruction
175. Ong CK, Seymour RA, Lirk P, Merry AF. Combining paracetamol
(acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative
pain. Anesth Analg. 2010;110(4):1170–1179.
176. Doleman B, Heinink TP, Read DJ, Faleiro RJ, Lund JN, Williams
JP. A systematic review and meta-regression analysis of prophylactic gabapentin for postoperative pain. Anaesthesia. 2015;70(10):
1186–1204.
177. Clarke H, Bonin RP, Orser BA, Englesakis M, Wijeysundera DN, Katz
J. The prevention of chronic postsurgical pain using gabapentin and
pregabalin: a combined systematic review and meta-analysis. Anesth
Analg. 2012;115(2):428–442.
178. Ho KY, Gan TJ, Habib AS. Gabapentin and postoperative pain
– a systematic review of randomized controlled trials. Pain.
2006;126(1–3):91–101.
179. Mathiesen O, Moiniche S, Dahl JB. Gabapentin and postoperative
pain: a qualitative and quantitative systematic review, with focus on
procedure. BMC Anesthesiol. 2007;7:6.
180. Castelino T, Fiore JF Jr, Niculiseanu P, Landry T, Augustin B, Feldman LS. The effect of early mobilization protocols on postoperative
outcomes following abdominal and thoracic surgery: a systematic
review. Surgery. 2016;159(4):991–1003.
181. Epstein NE. A review article on the benefits of early mobilization
following spinal surgery and other medical/surgical procedures. Surg
Neurol Int. 2014;5(suppl 3):S66–S73.
182. Yeung JK, Harrop R, McCreary O, et al. Delayed mobilization after
microsurgical reconstruction: an independent risk factor for pneumonia. Laryngoscope. 2013;123(12):2996–3000.
183. Griffiths R, Fernandez R. Strategies for the removal of short-term
indwelling urethral catheters in adults. Cochrane Database Syst Rev.
2007;2:CD004011.
184. Ramanathan R, Duane TM. Urinary tract infections in surgical patients.
Surg Clin North Am. 2014;94(6):1351–1368.
185. Zhang P, Hu WL, Cheng B, Cheng L, Xiong XK, Zeng YJ. A systematic
review and meta-analysis comparing immediate and delayed catheter
removal following uncomplicated hysterectomy. Int Urogynecol J.
2015;26(5):665–674.
186. Charoenkwan K, Matovinovic E. Early versus delayed oral fluids and
food for reducing complications after major abdominal gynaecologic
surgery. Cochrane Database Syst Rev. 2014;12:CD004508.
187. Willcutts KF, Chung MC, Erenberg CL, Finn KL, Schirmer BD,
Byham-Gray LD. Early oral feeding as compared with traditional timing of oral feeding after upper gastrointestinal surgery: a systematic
review and meta-analysis. Ann Surg. 2016;264(1):54–63.
188. Lee VS, Kawamoto K, Hess R, et al. Implementation of a value-driven
outcomes program to identify high variability in clinical costs and
outcomes and association with reduced cost and improved quality.
JAMA. 2016;316(10):1061–1072.

Dovepress
The manuscript management system is completely online and includes
a very quick and fair peer-review system, which is all easy to use. Visit
http://www.dovepress.com/testimonials.php to read real quotes from
published authors.

Submit your manuscript here: https://www.dovepress.com/journal-of-pain-research-journal

Journal of Pain Research 2018:11

submit your manuscript | www.dovepress.com

Dovepress

Powered by TCPDF (www.tcpdf.org)

1581

